Table 2.

CD8⁺ donor-specific (dsp CD8 pf) and CD8⁺ third-party precursor frequency (third-party CD8 pf), cytomegalovirus (CMV) serostatus before transplantation, the number of days from transplantation to rejection and type of rejection of each individual transplant recipient.

Non-rejectors	dsp CD8 pf	3rd-party CD8 pf	CMV serology before transplantation	Days between Tx and acute rejection	Banff classification
1	2·78	3·50	+
2	2·77	8·26	+
3	4·08	5·49	+
4	2·00	7·21	−
5	6·12	8·98	+
6	8·88	8·12	+
7	4·80	8·46	−
8	4·66	4·32	+
9	7·82	8·31	+
10	4·97	11·80	-
11	0·58	3·38	+
12	3·69	7·23	−
13	1·01	3·50	+
14	6·44	11·10	+
15	1·94	6·48	+
16	1·00	4·87	+
17	0·85	6·90	+
18	6·93	8·12	+
19	1·25	2·50	−
20	3·21	3·72	+
21	2·96	4·32	+
22	6·63	10·50	+
Rejectors
1	7·78	7·95	+	45	ACR IIa
2	1·23	4·07	+	33	ACR Ia
3	7·80	10·90	+	8	ACR IIa
4	2·20	4·01	+	38	ACR Ia
5	8·54	5·04	+	9	ACR Ib
6	7·35	7·54	+	35	ACR Ib
7	6·97	19·20	+	28	ACR IIa
8	1·69	4·27	−	24	ACR Ib
9	5·32	15·70	+	10	ACR Ia
10	3·88	4·71	−	10	ACR IIb
11	7·29	6·29	+	7	ACR IIa
12	7·32	12·90	−	29	No material
13	7·17	5·00	+	27	ACR IIb
14	2·55	5·64	−	13	ACR Ia
15	2·59	3·61	+	9	No material
16	2·03	5·64	−	55	ACR Ia
17	3·82	4·80	+	41	ACR IIa
18	3·41	2·23	+	28	ACR III
19	1·00	3·97	+	31	ACR IIa
20	5·97	15·30	+	11	ACR IIa
21	7·31	13·90	+	6	ACR IIa
22	2·18	4·72	−	13	ACR Ia
23	17·00	11·40	+	23	ACR Ib
24	7·60	7·37	+	38	ACR Ia